Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Custodiol-N vs Custodiol for pediatric heart transplantation organ preservation
2022-001795-34Phase 2Active
- Sponsor
- Franz Köhler Chemie
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in heart transplantation comparing Custodiol-N preservation with Custodiol preservation (2 arms). Primary endpoint: Safety assessment (adverse events). Started Sep 2022; status: active.
02
Drugs
histidine-tryptophan-ketoglutarate solution (modified)HTK Custodiol
03
Conditions
heart transplantation
Beyond the preview
Go deeper on 2022-001795-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001795-34.